These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9679700)

  • 41. Melanocyte reservoir in vitiligo.
    Arrunátegui A; Arroyo C; Garcia L; Covelli C; Escobar C; Carrascal E; Falabella R
    Int J Dermatol; 1994 Jul; 33(7):484-7. PubMed ID: 7928031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo.
    Kaufmann R; Greiner D; Kippenberger S; Bernd A
    Acta Derm Venereol; 1998 Mar; 78(2):136-8. PubMed ID: 9534893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation.
    Jin Y; Xu A; Wang P; Song X; Liu X
    Cutis; 2011 Mar; 87(3):137-41. PubMed ID: 21488571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes.
    Falabella R; Escobar C; Borrero I
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):230-6. PubMed ID: 1552058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of vitiligo.
    Nordlund JJ; Halder RM; Grimes P
    Dermatol Clin; 1993 Jan; 11(1):27-33. PubMed ID: 8435915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of suction blister and carbon dioxide laser for recipient site preparation in epidermal grafting of segmental vitiligo.
    Lee DY; Choi SC; Lee JH
    Clin Exp Dermatol; 2010 Apr; 35(3):328-9. PubMed ID: 19758388
    [No Abstract]   [Full Text] [Related]  

  • 51. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo.
    Falabella R; Escobar C; Borrero I
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):257-64. PubMed ID: 2768575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliable site for suction blister induction and harvesting.
    Laxmisha C; Thappa DM
    Indian J Dermatol Venereol Leprol; 2005; 71(5):321-4. PubMed ID: 16394455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noncultured Epidermal Suspension in Vitiligo-A Review of Origins, Modifications, and Innovations for this Surgical Masterstroke!
    Mhatre M; Sharma A; Srihari S; Goldust M
    Skinmed; 2021; 19(6):419-423. PubMed ID: 35022112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of suction blisters for recipient site in epidermal grafting: the implications for vitiligo.
    Lee DY
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):241-2. PubMed ID: 18462307
    [No Abstract]   [Full Text] [Related]  

  • 55. Autologous Biological Dressing for the Recipient Area in Cellular Grafting of Vitiligo.
    Gupta S; Shankar Jangra R; Ashique KT; Gupta S
    Dermatol Surg; 2018 Jun; 44(6):895-896. PubMed ID: 28538029
    [No Abstract]   [Full Text] [Related]  

  • 56. Transplantation of melanocytes in vitiligo.
    Olsson MJ; Juhlin L
    Br J Dermatol; 1995 Apr; 132(4):587-91. PubMed ID: 7748750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of stable vitiligo with autologous epidermal grafting and PUVA.
    Shenoi SD; Srinivas CR; Pai S
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):802-3. PubMed ID: 9146554
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination of short-pulsed CO2 laser resurfacing and cultured epidermal sheet autografting in the treatment of vitiligo: a preliminary report.
    Toriyama K; Kamei Y; Kazeto T; Yasue T; Suga Y; Inoie M; Tomita Y; Torii S
    Ann Plast Surg; 2004 Aug; 53(2):178-80. PubMed ID: 15269591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of suction blister epidermal grafting and automated blister epidermal micrograft in stable vitiligo.
    Gao PR; Wang CH; Lin YJ; Huang YH; Chang YC; Chung WH; Ng CY
    Sci Rep; 2022 Jan; 12(1):393. PubMed ID: 35013472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dermatosurgical techniques for repigmentation of vitiligo.
    Rusfianti M; Wirohadidjodjo YW
    Int J Dermatol; 2006 Apr; 45(4):411-7. PubMed ID: 16650168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.